Protalix BioTherapeutics, Inc.

Direct answer

Protalix BioTherapeutics, Inc. is publicly traded on AMEX under the ticker PLX.

Established in 1993 and based in Hackensack, New Jersey, Protalix BioTherapeutics, Inc. is a biopharmaceutical company primarily focused on advancing and globally commercializing recombinant therapeutic proteins. The firm utilizes its proprietary ProCellEx plant cell-based protein expression system to develop these treatments, reaching patients in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey,...

Can you invest in Protalix BioTherapeutics, Inc.?

Yes. Protalix BioTherapeutics, Inc. trades publicly on AMEX as PLX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Protalix BioTherapeutics, Inc.

Detailed equity research is provided by MarketSnap.